Pierre R. Theodore

M.D. Vice President, Scientific Innovation, Thoracic Surgical Oncology
Johnson & Johnson

Biography

Pierre R. Theodore is Vice President, Therapeutic Area Expert, Thoracic Surgical Oncology for Johnson & Johnson Medical Devices Companies. In this role, he is responsible to help accelerate innovation, advance the standard of care within early stage science and to elevate existing and adjacent technologies.  Additionally, Dr. Theodore is a Health Sciences Associate Professor of Surgery and holds the Van Auken Endowed Chair in Thoracic Surgery at The University of California, San Francisco School of Medicine.

He has over two decades of experience in cardiothoracic surgery, surgical education, entrepreneurship and innovation.   Pierre’s practice focused on minimally invasive surgical approaches in thoracic surgery, interventional pulmonary procedures, and Global Surgery initiatives to expand surgical capacity in low-income countries.

Pierre has engaged in innovation across a wide range of domains including:  health informatics, surgical oncology, and post-surgical rehabilitation.  Pierre has founded and served in leadership roles in several start-up companies devoted to health information technology and integrated care and is a co-inventor of several medical devices and drug delivery platforms.  

Pierre has served as an advisor to numerous venture capital and private equity firms in Silicon Valley, helping to guide strategy in healthcare investments across the digital health, biotech, and medical device sectors.  Pierre is a commissioned officer in the United States Navy Reserve Medical Officer Corps, holding the rank of Commander.

After obtaining an undergraduate degree in Philosophy from Princeton University, Pierre received his Doctor of Medicine from the University of Virginia.  He completed general surgical and cardiothoracic surgical training at Johns Hopkins Hospital and  Hôpital Universitaire Pitié-Salpêtrière in Paris. Pierre completed a post-doctoral fellowship at the Massachusetts General Hospital Transplant Biology Research Center, Harvard Medical School